CONSOLIDATED STATEMENTS OF EQUITY - USD ($) $ in Thousands	Total	Cumulative Effect, Period of Adoption, Adjustment	Common Stock	Treasury	Additional Paid-In Capital	Additional Paid-In Capital Cumulative Effect, Period of Adoption, Adjustment	Accumulated Other Comprehensive Income (loss)	Accumulated Deficit	Accumulated Deficit Cumulative Effect, Period of Adoption, Adjustment
Beginning balance, shares (in shares) at Dec. 31, 2020			670,585,576
Beginning balance, shares (in shares) at Dec. 31, 2020				(549,907)
Beginning balance at Dec. 31, 2020	$ 1,671,551		$ 6,706	$ (1,791)	$ 3,152,694		$ (4,225)	$ (1,481,833)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity-based compensation expense	9,929				9,929
Exercise of common stock options and warrants (in shares)			359,812
Exercise of common stock options and warrants	879		$ 4		875
2025 convertible notes (in shares)			19,051,270	(8,105,175)
2025 convertible notes	55,275		$ 190		55,085
Net income (loss)	43,631							43,631
Other comprehensive loss	(15,698)						(15,698)
Ending balance, shares (in shares) at Sep. 30, 2021			689,996,658
Ending balance, shares (in shares) at Sep. 30, 2021				(8,655,082)
Ending balance at Sep. 30, 2021	1,765,567		$ 6,900	$ (1,791)	3,218,583		(19,923)	(1,438,202)
Beginning balance, shares (in shares) at Dec. 31, 2020			670,585,576
Beginning balance, shares (in shares) at Dec. 31, 2020				(549,907)
Beginning balance at Dec. 31, 2020	$ 1,671,551		$ 6,706	$ (1,791)	3,152,694		(4,225)	(1,481,833)
Ending balance, shares (in shares) at Dec. 31, 2021			690,082,283
Ending balance, shares (in shares) at Dec. 31, 2021	(8,655,082)			(8,655,082)
Ending balance at Dec. 31, 2021	$ 1,685,126	$ (21,642)	$ 6,901	$ (1,791)	3,222,487	$ (39,100)	(30,495)	(1,511,976)	$ 17,458
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Accounting Standards Update [Extensible List]	Accounting Standards Update 2020-06
Beginning balance, shares (in shares) at Jun. 30, 2021			689,817,971
Beginning balance, shares (in shares) at Jun. 30, 2021				(8,655,082)
Beginning balance at Jun. 30, 2021	$ 1,742,585		$ 6,898	$ (1,791)	3,214,351		(9,932)	(1,466,941)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity-based compensation expense	3,822				3,822
Exercise of common stock options and warrants (in shares)			178,687
Exercise of common stock options and warrants	412		$ 2		410
Net income (loss)	28,739							28,739
Other comprehensive loss	(9,991)						(9,991)
Ending balance, shares (in shares) at Sep. 30, 2021			689,996,658
Ending balance, shares (in shares) at Sep. 30, 2021				(8,655,082)
Ending balance at Sep. 30, 2021	$ 1,765,567		$ 6,900	$ (1,791)	3,218,583		(19,923)	(1,438,202)
Beginning balance, shares (in shares) at Dec. 31, 2021			690,082,283
Beginning balance, shares (in shares) at Dec. 31, 2021	(8,655,082)			(8,655,082)
Beginning balance at Dec. 31, 2021	$ 1,685,126	$ (21,642)	$ 6,901	$ (1,791)	3,222,487	$ (39,100)	(30,495)	(1,511,976)	$ 17,458
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity-based compensation expense	15,315				15,315
Exercise of common stock options and warrants (in shares)			629,837
Exercise of common stock options and warrants	(688)		$ 7		(695)
ModeX Acquisition (in shares)			90,629,111
ModeX Acquisition	221,662		$ 906		220,756
Net income (loss)	(243,174)							(243,174)
Other comprehensive loss	$ (27,531)						(27,531)
Ending balance, shares (in shares) at Sep. 30, 2022			781,341,231
Ending balance, shares (in shares) at Sep. 30, 2022	(8,655,082)			(8,655,082)
Ending balance at Sep. 30, 2022	$ 1,629,068		$ 7,814	$ (1,791)	3,418,763		(58,026)	(1,737,692)
Beginning balance, shares (in shares) at Jun. 30, 2022			780,591,681
Beginning balance, shares (in shares) at Jun. 30, 2022				(8,655,082)
Beginning balance at Jun. 30, 2022	1,718,799		$ 7,806	$ (1,791)	3,413,556		(49,171)	(1,651,601)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Equity-based compensation expense	3,390				3,390
Exercise of common stock options and warrants (in shares)			27,750
Exercise of common stock options and warrants	(463)		$ 1		(464)
ModeX Acquisition (in shares)			721,800
ModeX Acquisition	2,288		$ 7		2,281
Net income (loss)	(86,091)							(86,091)
Other comprehensive loss	$ (8,855)						(8,855)
Ending balance, shares (in shares) at Sep. 30, 2022			781,341,231
Ending balance, shares (in shares) at Sep. 30, 2022	(8,655,082)			(8,655,082)
Ending balance at Sep. 30, 2022	$ 1,629,068		$ 7,814	$ (1,791)	$ 3,418,763		$ (58,026)	$ (1,737,692)